• Users Online: 25
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 

    Article Cited by others

VIEW POINT

Use of sodium-glucose co-transporter 2 inhibitors during the fasting of ramadan: Is there cause for concern?

Beshyah Salem A, Farooqi Muhammad Hamed, Suliman Sara GI, Benbarka Mahmoud

Year : 2016| Volume: 8| Issue : 3 | Page no: 81-88

   This article has been cited by
 
1 Evolving physicians’ perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting
Salem A. Beshyah,Khadija Hafidh,Tariq Gul Shaikh
Diabetes Research and Clinical Practice. 2020; 168: 108389
[Pubmed]  [Google Scholar] [DOI]
2 Diabetes und Migration
Sebahat Sat,Kadriye Aydinkoç-Tuzcu,Faize Berger,Alain Barakat,Karin Schindler,Peter Fasching
Der Diabetologe. 2020;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article